Company / Depreciation & Amortization
Stoke Therapeutics, Inc. Depreciation & Amortization History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.5M
FY2024
5-year range
$974.0K / $2.5M
FY2020-FY2024
Trend
+59.7%
vs FY2023
Sector context
#97 of 168
Health Care
What the data says
At $2M, Stoke Therapeutics, Inc.'s depreciation & amortization ranks #72 of 168 in the Health Care sector. Increased from $974,000 to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2024 with a 5-year CAGR of +40.6%.
Increased from $974,000 to $2M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +36.3%
- 5-Year CAGR
- +40.6%
- 10-Year CAGR
- -
Sector benchmark
#72 of 168 in Health CareTop 42% of 168This company $2.5M Sector average $212.9M
▼
-98.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +40.6%, indicating consistent growth.
- In FY2024, depreciation & amortization increased 59.7% year-over-year.
- Ranks #97 out of 168 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $2.5M | +59.7% |
| FY2023 | $1.5M | +58.7% |
| FY2022 | $974.0K | +0.0% |
| FY2021 | $974.0K | +9.7% |
| FY2020 | $888.0K | +97.3% |
| FY2019 | $450.0K | +110.3% |
| FY2018 | $214.0K | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026